DiaGenic ASA Provides Update on AMYtec™ Study

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic reports intermediate results from an exploratory study that examines the correlation between gene expression in blood and brain amyloid PET imaging. In an initial patient population of 100 patients, a correlation between brain amyloid load as measured by brain PET imaging and gene expression in peripheral blood was established. Additional data analyses and possibly additional patients are required to determine the degree of correlation and test accuracy.

Help employers find you! Check out all the jobs and post your resume.